DKSH Now Offers a Full Portfolio to Support Cell and Gene Therapy Manufacturing
As cell and gene therapies revolutionize treatment for cancer, rare diseases, and immunological disorders, DKSH is committed to supporting researchers and manufacturers with a specialized product range that meets the evolving demands of this dynamic field.
Through partnerships with trusted global suppliers, DKSH offers a comprehensive selection of high-quality, research-grade and GMP-grade reagents, supporting the full development pipeline from early-stage discovery to clinical-scale production. Whether you’re working on CAR-T, NK cell therapies, mRNA vaccines, or stem cell research, our portfolio is designed to enable scalable, regulatory-compliant, and reproducible workflows.
Our offering spans five core categories:
1. Enzymes & Reagents for GMP Manufacturing of Cell, Gene, and Other Biological Therapies
High-quality enzymes, cytokines, and processing reagents that meet GMP standards for manufacturing cell and gene therapies, vaccines, and other biologics. Our partners offer complete documentation packages, ensuring full traceability and compliance with regulatory requirements.
2. mRNA Raw Materials & Reagents
A full range of raw materials essential for in vitro transcription (IVT) and mRNA-based drug development, including cap analogs, modified nucleotides, and enzymes optimized for mRNA synthesis and purification.
3. Immune Cell Therapy (CAR-T/NK)
A robust portfolio of recombinant cytokines and activation factors for the ex vivo culture, expansion, and differentiation of CAR-T and NK cells. Offered in both RUO and GMP grades, these products support consistent and effective cell therapy development.
A robust portfolio of recombinant cytokines and activation factors for the ex vivo culture, expansion, and differentiation of CAR-T and NK cells. Offered in both RUO and GMP grades, these products support consistent and effective cell therapy development.
4. Stem Cell & iPSC Culture
Recombinant growth factors and supplements that enable the maintenance, reprogramming, and lineage-specific differentiation of stem cells and induced pluripotent stem cells (iPSCs). Ideal for both research and clinical translation.
Recombinant growth factors and supplements that enable the maintenance, reprogramming, and lineage-specific differentiation of stem cells and induced pluripotent stem cells (iPSCs). Ideal for both research and clinical translation.
5. Hematopoietic & Supportive Factors
A wide selection of hematopoietic cytokines and supportive growth factors designed to promote the proliferation and differentiation of hematopoietic stem cells, supporting applications in transplantation, immunotherapy, and regenerative medicine.
A wide selection of hematopoietic cytokines and supportive growth factors designed to promote the proliferation and differentiation of hematopoietic stem cells, supporting applications in transplantation, immunotherapy, and regenerative medicine.
All products are manufactured to the highest quality standards, with available GMP-grade options and complete documentation including CoAs, CoOs, and safety data sheets, ensuring regulatory compliance and batch-to-batch consistency.
Whether you're in early-stage R&D or preparing for clinical trials, DKSH offers a reliable, one-stop solution to accelerate your cell and gene therapy workflows.
Discover more on DKSH Discover. Sign up to access our complete portfolio and technical resources, available in Australia.
